Quick Answer
ADC Therapeutics SA reported Earnings Per Share Diluted of $1.12 (loss) per share for the year ending 2025.
- ADC Therapeutics SA showed an increase of +30.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from ADC Therapeutics SA's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2022 to 2025), ADC Therapeutics SA's Earnings Per Share Diluted has grown by 44.3%.
- Historical annual values: Fiscal year 2025: $1.12 (loss) per share | Fiscal year 2024: $1.62 (loss) per share | Fiscal year 2023: $2.94 (loss) per share | Fiscal year 2022: $2.01 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: